Government Intervention Measures Effectively Control COVID-19 Epidemic in Wuhan, China


The Coronavirus disease 2019 (COVID-19) outbreak has been brought under control through a nationwide effort, and now it has become a global pandemic and the situation seems grim. We summarized the measures taken in Wuhan and analyzed the effects to comprehensively describe the factors involved in controlling the COVID-19 in China. In China, several measures such as the lockdown of Wuhan, restriction of traffic and communities, increasing hospital beds, nationwide support from medical staff, epidemic prevention equipment and supplies, and establishment of makeshift shelter hospitals have been taken. The lockdown of Wuhan reduced the propagation of cases to other cities in Hubei province and throughout China, traffic and community restrictions reduced the flow of population and the spread of disease, increasing wards and beds and medical personnel reduced the incidence of severe cases and mortality, the establishment of the Fangcang shelter hospitals provided a good isolation and monitoring environment, and further reduced the spread and fatality of the disease. The fact that China was able to control the spread of COVID-19 within three months without a specific drug or vaccine suggests that these measures are more adequate and effective.


  1. 1

    Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020,91:264–266

    CAS  Article  Google Scholar 

  2. 2

    Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020,323(11):1061–1069

    CAS  Article  Google Scholar 

  3. 3

    Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 2020,20(4):425–434

    CAS  Article  Google Scholar 

  4. 4

    Rockx B, Kuiken T, Herfst S, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science, 2020,368(6494): 1012–1015

    CAS  Article  Google Scholar 

  5. 5

    Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020,395(10223):514–523

    CAS  Article  Google Scholar 

  6. 6

    Xiao F, Tang M, Zheng X, et al. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology, 2020,158(6):1831–1833.e3

    CAS  Article  Google Scholar 

  7. 7

    Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis, 2020,92:214–217

    CAS  Article  Google Scholar 

  8. 8

    Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med, 2020,382(8):727–733

    CAS  Article  Google Scholar 

  9. 9

    Chen S, Zhang Z, Yang J, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet, 2020,395(10232):1305–1314

    CAS  Article  Google Scholar 

  10. 10

    Kraemer MUG, Yang CH, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science, 2020,368(6490):493–497

    CAS  Article  Google Scholar 

  11. 11

    Pan A, Liu L, Wang C, et al. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA, 2020,323(19):1915–1923

    CAS  Article  Google Scholar 

  12. 12

    Liu M, Ning J, Du YR, et al. Modeling the Evolution Trajectory of COVID-19 in Wuhan, China: Experience and Suggestions. Public Health, 2020,183:76–80

    CAS  Article  Google Scholar 

  13. 13

    Baidu migration index., Accessed on March 11, 2020.

  14. 14

    New coronavirus pneumonia prevention and control program (5th ed.) (Chinese). 2020. Available at:

  15. 15

    Wang CL, Liu L, Hao XJ, et al. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. Available at:

  16. 16

    Yang Z, Zeng Z, Wang K, et al. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis, 2020,12(3):165–174

    Article  Google Scholar 

  17. 17

    Adams JG, Walls RM. Supporting the Health Care Workforce During the COVID-19 Global Epidemic. JAMA, 2020,323(15):1439–1440

    CAS  Article  Google Scholar 

  18. 18

    Tong ZD, Tang A, Li KF, et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis, 2020,26(5):1052–1054

    CAS  Article  Google Scholar 

  19. 19

    Li P, Fu JB, Li KF, et al. Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster. Int J Infect Dis, 2020,96:452–453

    CAS  Article  Google Scholar 

  20. 20

    Li C, Ji F, Wang L, et al. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China. Emerg Infect Dis, 2020,26(7): 1626–1628

    CAS  Article  Google Scholar 

Download references


We are very grateful to the National Health Commission of the People’s Republic of China, Health Commission of Hubei Province and Wuhan Municipal Health Commission for providing reliable source of information.

Author information



Corresponding authors

Correspondence to Shao-shuai Wang or Ling Feng.

Additional information

Conflict of Interest Statement

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xin, X., Li, Sf., Cheng, L. et al. Government Intervention Measures Effectively Control COVID-19 Epidemic in Wuhan, China. CURR MED SCI 41, 77–83 (2021).

Download citation

Key words

  • COVID-19
  • mainland China
  • government intervention measures
  • healthcare